NuvOx Therapeutics files for IPO on NYSE American

NuvOx Therapeutics, Inc. has filed for an initial public offering of common stock, with an anticipated price range of $6.00 to $8.00 per share, according to a press release statement.

The company plans to list its shares on NYSE American under the ticker symbol NUOX, pending final approval from the exchange. ThinkEquity is serving as the underwriter for the offering.

Prior to this offering, there has been no public market for NuvOx Therapeutics common stock.

You May Also Be Interested In

• U.S. debt tops $40 trillion
• Polar Power targets military drone and robotics power market
• Hyperliquid Strategies to webcast fiscal year 2026 results